首页 | 本学科首页   官方微博 | 高级检索  
     


PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy
Authors:Lisa?Bodei  author-information"  >  author-information__contact u-icon-before"  >  mailto:bodeil@mskcc.org"   title="  bodeil@mskcc.org"   itemprop="  email"   data-track="  click"   data-track-action="  Email author"   data-track-label="  "  >Email author,Mark?S.?Kidd,Aviral?Singh,Wouter?A.?van der?Zwan,Stefano?Severi,Ignat?A.?Drozdov,Jaroslaw?Cwikla,Richard?P.?Baum,Dik?J.?Kwekkeboom,Giovanni?Paganelli,Eric?P.?Krenning,Irvin?M.?Modlin
Affiliation:1.Molecular Imaging and Therapy Service, Department of Radiology,Memorial Sloan Kettering Cancer Center,New York,USA;2.LuGenIum Consortium, Milan, Rotterdam, London, Bad Berka,London,UK;3.Wren Laboratories,Branford,USA;4.Theranostics Center for Molecular Radiotherapy and Imaging,Zentralklinik Bad Berka,Bad Berka,Germany;5.Department of Radiology and Nuclear Medicine,Erasmus University Medical Center,Rotterdam,The Netherlands;6.Nuclear Medicine and Radiometabolic Units,Instituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,Meldola,Italy;7.University of Warmia and Mazury,Olsztyn,Poland;8.Cyclotron Rotterdam BV,Erasmus University Medical Center,Rotterdam,The Netherlands;9.Yale School of Medicine,New Haven,USA
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号